Axim Biotechnologies, Inc.
AXIM· OTC
Filed Apr 15, 2013 · 10-K · 105 days after period end · 0001514955-13-000012
derived · Computed from the longer spans the company filed.
| Metric | Q4 2012dderived from reported figures | Q4 2011dderived from reported figures |
|---|---|---|
| Revenue | $10.83K | $10.00K |
| Net Income | -$16.55K | $1.22K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Axim Biotechnologies, Inc. · CIK 1514946 · Engraved from SEC EDGAR
ended Dec 31, 2012 · filed Apr 15, 2013 · 105 d after period end